N
LAB icon

Nuveen’s Standard BioTools LAB Stock Holding History

Nuveen’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$608K Buy
661,204
+3,992
+0.6% +$4.83K ﹤0.01% 2767
2025
Q4 		$841K Hold
657,212
– – ﹤0.01% 2690
2025
Q3 		$854K Hold
657,212
– – ﹤0.01% 2692
2025
Q2 		$789K Sell
657,212
-141,270
-18% -$157K ﹤0.01% 2700
2025
Q1 		$862K Hold
798,482
– – ﹤0.01% 2701
2024
Q4 		$1.4M Sell
798,482
-24,003
-3% -$44.7K ﹤0.01% 2540
2024
Q3 		$1.59M Buy
822,485
+39,333
+5% +$77K ﹤0.01% 2534
2024
Q2 		$1.39M Buy
+783,152
New +$1.91M ﹤0.01% 2564
2022
Q2 		– Sell
-1,599,180
Closed -$5.87M – 3382
2022
Q1 		$5.87M Sell
1,599,180
-355,906
-18% -$1.23M ﹤0.01% 1971
2021
Q4 		$7.66M Buy
1,955,086
+23,251
+1% +$109K ﹤0.01% 1847
2021
Q3 		$13.4M Buy
1,931,835
+292,032
+18% +$1.92M ﹤0.01% 1573
2021
Q2 		$10.1M Buy
1,639,803
+384,905
+31% +$2.06M ﹤0.01% 1856
2021
Q1 		$5.67M Buy
1,254,898
+57,419
+5% +$315K ﹤0.01% 2113
2020
Q4 		$7.18M Buy
1,197,479
+163,618
+16% +$1.07M ﹤0.01% 1892
2020
Q3 		$7.68M Sell
1,033,861
-83,293
-7% -$575K ﹤0.01% 1674
2020
Q2 		$4.48M Buy
1,117,154
+48,584
+5% +$169K ﹤0.01% 1960
2020
Q1 		$2.71M Sell
1,068,570
-928
-0.1% -$3.05K ﹤0.01% 2037
2019
Q4 		$3.72M Sell
1,069,498
-120,720
-10% -$425K ﹤0.01% 2142
2019
Q3 		$5.51M Buy
1,190,218
+63,977
+6% +$504K ﹤0.01% 1901
2019
Q2 		$13.9M Buy
+1,126,241
New +$14.3M 0.01% 1395

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Nuveen's LAB Position: Q1 2026 in Review

Nuveen increased its Standard BioTools (LAB) stake by 0.61% in Q1 2026, buying an estimated $4.83K and bringing the position to 661,204 shares worth $608K. The position accounts for ﹤0.01% of the portfolio, ranked #2767.

Nuveen first reported a position in LAB in Q2 2019 and has held it in 20 quarters since. The position peaked at $13.9M in Q2 2019. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

  • Nuveen held 661,204 shares of Standard BioTools worth $608K as of Q1 2026.
  • Nuveen bought 3,992 Standard BioTools shares in Q1 2026, an estimated $4.83K.
  • Standard BioTools made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #2767 holding.
  • Nuveen first reported a position in Standard BioTools in Q2 2019 and has held it in 20 quarters since.
  • Nuveen's Standard BioTools position peaked at $13.9M in Q2 2019.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.